FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to recombinant production of human leukotriene receptor type 1 (human cysteinyl leikotriene receptor 1, CysLTR1), and can be used for expression of CysLT1 receptor. Disclosed is a genetic construct with a nucleotide sequence which is optimized for expression of CysLTR1 in insect cells. Also, additional truncation of disordered C-end of CysLT1 receptor prevents formation of crystals.
EFFECT: invention provides recombinant expression in a eukaryotic system on a cell surface by combining N-terminal peptide fragments and the position of partner protein b562RIL in a third intracellular loop, which also stabilizes the protein and helps to form crystalline contacts.
1 cl, 3 dwg
Authors
Dates
2020-10-29—Published
2019-11-25—Filed